tirapazamine and Postoperative-Complications

tirapazamine has been researched along with Postoperative-Complications* in 1 studies

Other Studies

1 other study(ies) available for tirapazamine and Postoperative-Complications

ArticleYear
Hypoxia after liver surgery imposes an aggressive cancer stem cell phenotype on residual tumor cells.
    Annals of surgery, 2014, Volume: 259, Issue:4

    To assess the contribution of hypoxia and bone marrow-derived cells to aggressive outgrowth of micrometastases after liver surgery.. Liver surgery generates a microenvironment that fosters aggressive tumor recurrence. These areas are characterized by chronic hypoxia and influx of bone marrow-derived cells.. The contribution of hematopoietic cell types was studied in mice lacking specific components of the immune system and in irradiated mice lacking all bone marrow-derived cells. Tumor cells were derived from colorectal cancer patients and from a metastatic tumor cell line. Hypoxia-induced changes in stem cell and differentiation marker expression, clone-forming potential, and metastatic capacity were assessed. The effect of vascular clamping on cancer stem cell (CSC) characteristics was performed in mice bearing patient-derived liver metastases.. Immune cells and bone marrow-derived cells were not required for aggressive outgrowth of micrometastases in livers treated with surgery. Rather, hypoxia was sufficient to promote invasion and accelerate metastatic outgrowth. This was associated with a rapid loss of differentiation markers and increased expression of CSC markers and clone-forming capacity. Likewise, metastases residing in ischemia-reperfusion-injured liver lobes acquired CSC characteristics. Despite their renowned general resistance to chemotherapy, clone-forming CSCs were readily killed by the hypoxia-activated prodrug tirapazamine.. Surgery-generated hypoxia in the liver causes rapid dedifferentiation of tumor cells into immature CSCs with high clone- and metastasis-forming capacity. The results help explain the phenomenon of aggressive local tumor recurrence after liver surgery and offer a potential strategy to kill aggressive CSCs by hypoxia-activated prodrugs.

    Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Blotting, Western; Catheter Ablation; Cell Line, Tumor; Colorectal Neoplasms; Flow Cytometry; Hematopoietic Stem Cells; Hepatectomy; Humans; Hypoxia; Immunohistochemistry; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, Nude; Mice, SCID; Neoplasm Invasiveness; Neoplasm Micrometastasis; Neoplasm Recurrence, Local; Neoplasm, Residual; Neoplastic Stem Cells; Phenotype; Postoperative Complications; Real-Time Polymerase Chain Reaction; Reperfusion Injury; Tirapazamine; Triazines

2014